939 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
AGN Allergan plc. $162.09 $53.54B Downtrend
Article Searches
Tracking Mason Hawkins' Southeastern Asset Management Portfolio - Q4 2017 Update https://seekingalpha.com/article/4150470-tracking-mason-hawkins-southeastern-asset-management-portfolio-q4-2017-update?source=feed_all_articles Feb 25, 2018 - Mason Hawkins’ 13F portfolio value decreased from $8.32B to $8.08B this quarter. The number of positions increased from 27 to 30.Southeastern Asset Management added Allergan and increased Mattel while
Patent Office Puts Allergan's Mohawk Deal Out Of Its Misery https://seekingalpha.com/article/4150417-patent-office-puts-allergans-mohawk-deal-misery?source=feed_sector_healthcare Feb 24, 2018 - PTAB ruled the St. Regis Mohawk Tribe could not claim sovereign immunity to thwart an IPR for Restasis patents.AGN's IPR defense could be a formality at this point.MYL estimated it could meet FDA guid
Tracking Larry Robbins' Glenview Capital Management Portfolio - Q4 2017 Update https://seekingalpha.com/article/4150363-tracking-larry-robbins-glenview-capital-management-portfolio-q4-2017-update?source=feed_all_articles Feb 23, 2018 - Glenview Capital Management's 13F portfolio value increased from $17.23B to $18.50B this quarter. The number of positions increased from 56 to 58.Larry Robbins substantially increased Thermo Fisher Sc
Berkshire's 4th Quarter Buy Teva Appears Cheap and Troubled http://www.gurufocus.com/news/645719/berkshires-4th-quarter-buy-teva-appears-cheap-and-troubled Feb 23, 2018 - Berkshire's 4th Quarter Buy Teva Appears Cheap and Troubled, Stocks: BRK.A,BRK.B,TEVA, Warren Buffett, release date:Feb 23, 2018
Will Analysts Abandon Allergan On Esmya Headwinds? https://seekingalpha.com/article/4150026-will-analysts-abandon-allergan-esmya-headwinds?source=feed_sector_healthcare Feb 23, 2018 - The European Medicines Agency advised that no new patients take Esmya due to potential links to liver injury.The decision could stymie AGN's attempt to seek FDA approval for Esmya in the U.S.Another h
Larry Robbins' Top 5 New Buys in 4th Quarter http://www.gurufocus.com/news/645207/larry-robbins-top-5-new-buys-in-4th-quarter Feb 22, 2018 - Larry Robbins' Top 5 New Buys in 4th Quarter, Stocks: IQV,NWL,APTV,AGN,CHTR,THC, Larry Robbins, release date:Feb 22, 2018
Tracking Wallace Weitz's Weitz Investment Management Portfolio - Q4 2017 Update https://seekingalpha.com/article/4149658-tracking-wallace-weitzs-weitz-investment-management-portfolio-q4-2017-update?source=feed_all_articles Feb 22, 2018 - Wallace Weitz's 13F portfolio value decreased marginally from $2.43B to $2.40B. The number of positions decreased from 79 to 77.Weitz Investment Management increased Allergan while dropping United Par
Mason Hawkins’ Southeastern Bets Big on CenturyLink http://www.gurufocus.com/news/645111/mason-hawkins-southeastern-bets-big-on-centurylink Feb 22, 2018 - Mason Hawkins’ Southeastern Bets Big on CenturyLink, Stocks: CTL,AGN,GE,RLGY,CBPO,TV,MAT,CNX,BEL,CEIX,VIPS, Mason Hawkins, release date:Feb 22, 2018
Abbvie's Uterine Fibrosis Candidate Meets Goal in Study http://www.zacks.com/stock/news/293411/abbvies-uterine-fibrosis-candidate-meets-goal-in-study?cid=CS-ZC-FT-293411 Feb 22, 2018 - AbbVie's (ABBV) phase III study of its late stage candidate elagolix meets its primary endpoint in women with uterine fibroids.
Another Phase III Win For Neurocrine Biosciences https://seekingalpha.com/article/4149340-another-phase-iii-win-neurocrine-biosciences?source=feed_sector_healthcare Feb 22, 2018 - AbbVie announced that elagolix met its primary and secondary efficacy endpoints in the first of two Phase III studies for uterine fibroids. Uterine fibroids is another potential multibillion-dollar in

Pages: 123456...94

Page 1>

Related Companies

Name Exchange Price Mkt Cap
VRTX Vertex Pharmaceuticals Incorporated NASDAQ $165.9 $42.12B
ZTS Zoetis Inc. NYSE $82.79 $40.17B
SHPG Shire plc NASDAQ $127.08 $38.55B
CELG Celgene Corporation NASDAQ $95.61 $71.92B
REGN Regeneron Pharmaceuticals, Inc. NASDAQ $323.86 $34.88B
Sector: Health Care > Industry: Major Pharmaceuticals
DeepLinks for Allergan plc.
AGN - Google Finance https://www.google.com/finance?q=AGN Industry related info and international coverage Summary News
AGN - Bloomberg http://www.bloomberg.com/research/stocks/snapshot/snapshot.asp?ticker=AGN Original news and commentary from Bloomberg Charts Financials with pensions Snapshot Earnings Transactions People Options